highly significantp < 0.001
Colistin demonstrated an even stronger and highly significant upward trend (OR = 1.61, 95% CI 1.43–1.82, p < 0.001), corresponding to an estimated 61% annual increase in resistance odds, underscoring a concerning escalation in resistance to one of the last-resort agents.